OPKO Health Inc. (NASDAQ:OPK) at last check was buoying at $4.28 on Friday, January 14, with a fall of 0.00% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $4.28 and 5Y monthly beta was reading 1.68 with its price kept floating in the range of $4.26 and $4.53 on the day. Company’s P/E ratio for the trailing 12 months is 36.27. Considering stock’s 52-week price range provides that OPK hit a high price of $6.27 and saw its price falling to a low level of $3.26 during that period. Over a period of past 1-month, stock came adding 12.63% in its value.
With its current market valuation of $3.03 billion, OPKO Health Inc. is set to declare its quarterly results on Feb 16, 2022 – Feb 21, 2022. Analysts are in estimates of -$0.02 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to $0.04 for 2021 with estimates of that growing to $0.05 in next year. These estimates are suggesting current year growth of -20.00% for EPS and 25.00% growth next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $318.35 million. They suggested that in the process company could generate revenue of as low as $302.7 million which could climb up to $333.85 million to hit a high. The average estimate is representing a decrease of -35.60% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $1.69 billion in 2021, which will be 17.90% more from revenue generated by the company last year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review OPK stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 100% Buy for it.
Digging deeper we become aware of the PEG ratio of the OPK stock which is currently positioned at 3.02. It further provides that stock’s current price level is -7.37% away from its 20-day simple moving average and is -0.38% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 45.01 while volatility remained at 5.07% over the past week which changes to 6.30% when measuring it over the past month. Beta is valued at 1.73, while measure of average true range or ATR is currently at 0.25.
In comparing OPKO Health Inc. (OPK)’s stock with other industry players reveals that stock’s latest price change of 0.00% and that of -5.31% over the past 12 months is in competing position with that of Johnson & Johnson (JNJ) which saw its stock price fall by -0.65% in the recent trading and went through an increase of 5.05% in past 12-month trading. Industry’s another major player Bristol-Myers Squibb Company (BMY) has rise 0.05% up in latest trading session, but over the past year has faced afall of -2.15%, while Regeneron Pharmaceuticals Inc. (REGN) was also down -0.02% however its price remained floating in the green at 18.96% over the same period. OPKO Health Inc. has a P/E ratio of 36.27 against that of Johnson & Johnson’s 25.23. On the other hand, the S&P 500 Index is down -0.23% in the early deals today while the Dow Jones Industrial was dealinglower at -0.65%.
Having a second look at OPKO Health Inc. (NASDAQ:OPK) provides that stock’s average daily trading volume for 3 months was 4.48 million. Number of outstanding shares of the stock stood at 651.84 million.
The percentage of outstanding shares held by the insiders is 4.50% while it is 28.20% for the institutional holders. Subtraction of -11.02% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.